ACU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Acme United Corp (ACU) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks clear upward momentum, and the technical indicators do not signal a strong entry point. While the company has shown some growth in Q4 2025, the financial performance is mixed, and there are no significant positive catalysts or trading signals to justify immediate action.
The MACD is negatively expanding, indicating bearish momentum. RSI is neutral at 33.604, and moving averages are converging, showing no clear trend. The price is near the S1 support level of 43.384, but there is no strong indication of a reversal or breakout.
Acme United reported record sales of $196.5 million for Q4 2025, with European net sales increasing by 31%, driven by strong performance in the first aid product segment.
Net income and EPS for Q3 2025 dropped significantly YoY (-14.51% and -14.81%, respectively). The stock price has declined by 1.22% in the last session, and technical indicators suggest bearish momentum.
In Q4 2025, revenue increased by 3% YoY to $47.5 million, and net income rose to $1.9 million. However, Q3 2025 showed a decline in net income (-14.51% YoY) and EPS (-14.81% YoY), indicating inconsistent growth trends.
No analyst rating or price target data is available for ACU.
